Scott M Vouri, Pharm.D.,Ph.D., BCGP
Clinical Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6299
Business Email:
svouri@cop.ufl.edu
About Scott M Vouri
Scott Martin Vouri, Pharm.D., Ph.D., BCGP, joined the department of pharmaceutical outcomes and policy as a clinical assistant professor in 2018. Vouri also serves as the assistant director of pPharmacy Services with the University of Florida Health Physicians. He received his Pharm.D. at Butler University, completed a post-graduate year, or PGY,-1 residency in ambulatory care at the Iowa City VA Medical Center, and completed a PGY-2 residency in geriatrics at Texas Tech University Health Sciences Center in Dallas, Texas. He completed a Master of Science in Clinical Investigation at Washington University School of Medicine and Ph.D. in Epidemiology concentration at Saint Louis University College of Public Health and Social Justice. Vouri also received a KL2 Career Development Award through Washington University Institute of Clinical and Translational Sciences in 2015.
Board Certifications
-
Board Certified Geriatric PharmacistACCP
Research Profile
Pharmacoepidemiology, Pharmaceutical Health Service Research, Inappropriate Medication, Prescribing/ Deprescribing, Geriatric Medication Use, Medication Use following Bariatric Surgery and Urology
Open Researcher and Contributor ID (ORCID)
0000-0002-0411-2160
Publications
2021
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic.
Research in social & administrative pharmacy : RSAP.
17(1):2012-2017
[DOI] 10.1016/j.sapharm.2020.04.031.
[PMID] 32409150.
2020
Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic.
Research in social & administrative pharmacy : RSAP.
[DOI] 10.1016/j.sapharm.2020.11.005.
[PMID] 33221267.
2020
Student Pharmacists’ Ability to Organize Complex Medication Regimens According to the Universal Medication Schedule.
American journal of pharmaceutical education.
84(8)
[DOI] 10.5688/ajpe7531.
[PMID] 32934380.
2020
Rhinorrhea as a Result of Alzheimer’s Disease Treatment.
The Senior care pharmacist.
35(4):148-149
[DOI] 10.4140/TCP.n.2020.148..
[PMID] 32192562.
2020
Impact of Anticholinergic Medication Burden on Mobility and Falls in the Lifestyle Interventions for Elders (LIFE) Study.
Journal of clinical medicine.
9(9)
[DOI] 10.3390/jcm9092989.
[PMID] 32947839.
2020
Twelve-year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States.
Diabetes, obesity & metabolism.
22(4):705-710
[DOI] 10.1111/dom.13949.
[PMID] 31903713.
2020
Evaluation of a ceiling effect on the association of new resistance development to antipseudomonal beta-lactam exposure in the critically ill.
Infection control and hospital epidemiology.
41(4):484-485
[DOI] 10.1017/ice.2019.381.
[PMID] 31983358.
2020
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Journal of the American Pharmacists Association : JAPhA.
[DOI] 10.1016/j.japh.2020.09.013.
[PMID] 33127312.
2020
Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions.
The journal of pain.
[DOI] 10.1016/j.jpain.2020.09.002.
[PMID] 33031943.
2020
Evaluation of the Potential Acetylcholinesterase Inhibitor-Induced Rhinorrhea Prescribing Cascade.
Journal of the American Geriatrics Society.
68(2):440-441
[DOI] 10.1111/jgs.16224.
[PMID] 31625144.
2020
Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions.
JAMA network open.
3(2)
[DOI] 10.1001/jamanetworkopen.2020.0234.
[PMID] 32108887.
2019
Antimuscarinic use and discontinuation in an older adult population.
Archives of gerontology and geriatrics.
80:1-11
[DOI] 10.1016/j.archger.2018.09.005.
[PMID] 30268971.
2019
Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.
Pharmacotherapy.
39(3):261-270
[DOI] 10.1002/phar.2201.
[PMID] 30506852.
2019
Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
JAMA network open.
2(12)
[DOI] 10.1001/jamanetworkopen.2019.18425.
[PMID] 31880802.
2019
Relative Risk of Adverse Events and Treatment Discontinuations Between Older and Non-Older Adults Treated with Antimuscarinics for Overactive Bladder: A Systematic Review and Meta-Analysis.
Drugs & aging.
36(7):639-645
[DOI] 10.1007/s40266-019-00674-9.
[PMID] 31054113.
2019
Scoring, Clinical Utility, and Psychometric Properties of the In-Home Medication Management Performance Evaluation (HOME-Rx).
The American journal of occupational therapy : official publication of the American Occupational Therapy Association.
73(2):7302205060p1-7302205060p8
[DOI] 10.5014/ajot.2019.029793.
[PMID] 30915967.
2018
Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.
Drugs & aging.
35(4):321-331
[DOI] 10.1007/s40266-018-0531-9.
[PMID] 29492862.
2018
An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.
Journal of the American Pharmacists Association : JAPhA.
58(5):534-539.e4
[DOI] 10.1016/j.japh.2018.06.014.
[PMID] 30033126.
2018
Antidiabetic medication de-escalation following bariatric surgery.
Journal of diabetes.
10(9):768-770
[DOI] 10.1111/1753-0407.12779.
[PMID] 29736976.
2018
Antimuscarinic Use in Men Treated With Bladder Outlet Obstruction Medication Therapy.
Urology.
122:76-82
[DOI] 10.1016/j.urology.2018.08.039.
[PMID] 30205105.
2018
Immunosuppressants and risk of Parkinson disease.
Annals of clinical and translational neurology.
5(7):870-875
[DOI] 10.1002/acn3.580.
[PMID] 30009205.
2017
Faculty perception of team-based learning over multiple semesters.
Currents in pharmacy teaching & learning.
9(6):1010-1015
[DOI] 10.1016/j.cptl.2017.07.004.
[PMID] 29233368.
2017
Impact of co-investigators on pharmacy resident research publication.
Pharmacy practice.
15(2)
[DOI] 10.18549/PharmPract.2017.02.928.
[PMID] 28690694.
2017
Successful intervention to mitigate an acetylcholinesterase inhibitor-induced rhinorrhea prescribing cascade: a case report.
Journal of clinical pharmacy and therapeutics.
42(3):370-371
[DOI] 10.1111/jcpt.12511.
[PMID] 28251653.
2017
Treated-and-released urinary catheterization in the emergency department by sex.
American journal of infection control.
45(8):905-910
[DOI] 10.1016/j.ajic.2017.02.025.
[PMID] 28410824.
2017
Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.
Archives of gerontology and geriatrics.
69:77-96
[DOI] 10.1016/j.archger.2016.11.006.
[PMID] 27889591.
2016
Impact of resident research publication on early-career publication success.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
73(12):895-900
[DOI] 10.2146/ajhp150567.
[PMID] 27261240.
2015
Changes in Mood in New Enrollees at a Program of All-Inclusive Care for the Elderly.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
30(8):463-71
[DOI] 10.4140/TCP.n.2015.463.
[PMID] 26260643.
2015
Comments on: Validity and Reliability of a Systematic Database Search Strategy to Identify Publications Resulting From Pharmacy Residency Research Projects.
Journal of pharmacy practice.
28(6):497-8
[DOI] 10.1177/0897190015607343.
[PMID] 26423922.
2015
Pharmacy resident publication success: factors of success based on abstracts from a regional meeting.
Currents in pharmacy teaching & learning.
7(6):780-786
[PMID] 26644798.
View on:
PubMed
2015
The Importance of Research during Pharmacy Residency Training.
Currents in pharmacy teaching & learning.
7(6):892-898
[PMID] 26594260.
View on:
PubMed
2014
Use of onabotulinumtoxinA for overactive bladder with concomitant warfarin.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
29(7):480-6
[DOI] 10.4140/TCP.n.2014.480.
[PMID] 25203108.
2014
Mirabegron: a Beta-3 agonist for overactive bladder.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
29(12):823-37
[DOI] 10.4140/TCP.n.2014.823.
[PMID] 25521658.
2013
Bisphosphonate use in patients undergoing dialysis.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
28(11):738-41
[DOI] 10.4140/TCP.n.2013.738.
[PMID] 24217193.
2013
Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia.
Pharmacotherapy.
33(6):639-49
[DOI] 10.1002/phar.1243.
[PMID] 23529917.
2013
Use of a medication reconciliation tool in an outpatient geriatric clinic.
Journal of the American Pharmacists Association : JAPhA.
53(6):652-8
[DOI] 10.1331/JAPhA.2013.13084.
[PMID] 24185492.
2013
A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV.
HIV/AIDS (Auckland, N.Z.).
5:263-74
[DOI] 10.2147/HIV.S36311.
[PMID] 24068878.
2012
Effects of oral bisphosphonate therapy on serum calcium in elderly veterans with poor kidney function.
The American journal of geriatric pharmacotherapy.
10(3):178-84
[DOI] 10.1016/j.amjopharm.2012.04.001.
[PMID] 22542895.
2012
HIV: a growing concern in the elderly population.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
27(5):358-64
[DOI] 10.4140/TCP.n.2012.358.
[PMID] 22591980.
2012
The ins and outs of pharmacy services at a program of all-inclusive care for the elderly.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
27(11):803-7
[DOI] 10.4140/TCP.n.2012.803.
[PMID] 23168930.
2011
Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes.
Journal of managed care pharmacy : JMCP.
17(4):304-12
[PMID] 21534641.
View on:
PubMed
Grants
Jun 2020
ACTIVE
Razanne Oueini – Characterization of the concurrent prescribing of non-benzodiazepine hypnotics, opioids, and CNS-depressing medications
Role: Principal Investigator
Funding: AMER FOU FOR PHARM EDU
Education
Ph.D.
2018
·
Saint Louis University
M.S.
2015
·
Washington University in St. Louis
Pharm.D.
2009
·
Butler University
Teaching Profile
Courses Taught
2020
PHA5226C Pt Safety and Quality
2020-2021
PHA7979 Advanced Research
2020-2021
PHA6910 Supervised Research
2020-2021
PHA7980 Research for Doctoral Dissertation
2020-2021
PHA5165L Prof Skills Lab V
2019-2020
PHA6938 Research Seminar
2020-2021
PHA6971 Research for Master’s Thesis
2019,2021
PHA6940 Supervised Teaching
2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6937 Topics in Pharmaceutical Administration
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
Contact Details
Phones:
- Business:
- (352) 273-6299
Emails:
- Business:
- svouri@cop.ufl.edu
Recent news
Deprescribing CV medications may benefit elderly patients with evolving treatment goals
Dr. Scott Martin Vouri is quoted in Cardiology Today’s October cover story on deprescribing CV medications.
U.S. Deprescribing Research Network selects Dr. Scott Martin Vouri as 2020-21 junior investigator
Scott Martin Vouri, Pharm.D., Ph.D., an assistant professor in the department of pharmaceutical outcomes and policy, was recently selected to the U.S. Deprescribing Research Network, or USDeN, Junior Investigative Intensive…
UF study finds excess use of loop diuretics following initiation of dihydropyridine calcium channel blockers
The study published in JAMA Network Open found a substantial number of patients are being prescribed a loop diuretic for leg swelling induced by calcium channel blocker.
Dr. Scott M. Vouri selected to the JAGS Junior Reviewer Program
Vouri was one of 18 junior faculty members selected to serve the Journal of the American Geriatrics Society.